Search
for
Sort by
Research 91–120 of 410
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- 5α-Reductases In Human Physiology: an Unfolding Story
- 5α-Reductases in Human Physiology: An Unfolding Story
- Witnessed trauma exposure induces fear in mice through a reduction in endogenous neurosteroid synthesis
- Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: alone or in combination with other treatments
- Active pharmaceutical ingredient-ionic liquids assisted follicular co-delivery of ferulic acid and finasteride for enhancing targeted anti-alopecia
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants
- Testicular Steroidogenesis
- Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field
- Clinical biochemistry of dihydrotestosterone
- Finasteride Use Does Not Lead to Depression or Suicide: Insights From a Large‐Scale Cohort Study and Mendelian Randomization Analysis
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- An updated landscape of Female Pattern Hair Loss
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Network Pharmacology Reveals Curcuma aeruginosa Roxb. Regulates MAPK and HIF-1 Pathways to Treat Androgenetic Alopecia
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Pharmacogenetics of the Androgen Metabolic Pathway
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives
- Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia
- Post-finasteride syndrome - a true clinical entity?